http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-097199-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
filingDate 2014-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37350f62fe16bb7b0d5132030ebf49c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_247f718ac636a9412856abd4df673441
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f53a440b1e6883eb6c621d67ef2c23f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7614ff3b7a4da4077c2728ab00b22049
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e4b2edbee91cea10ad9f820baae6dcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d5ad1d093414771a20c413b6e00fdd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd474acb1ac2addbfe3e7764e6d9f015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c573a9f34194a9fe4971fd5dffec87b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02acd59c7a39115616aa8014e2a35199
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c2610fae0f5390612f432f96c29967f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7bbb60e984c736a39dec4544dc7d680
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_543e09b4d92626a9ddf93e558c30c390
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8885aad60e3c7e72b10477d58e94182e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3cc0f91878003f0899daf7a465a2e3e
publicationDate 2016-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-097199-A1
titleOfInvention RORC2 INHIBITORS AND THEIR METHODS OF USE
abstract Compounds, pharmaceutical compositions, methods for inhibiting the activity of RORg and / or reducing the amount of IL-17 in a subject, and methods for treating various medical disorders using these compounds and pharmaceutical compositions. Useful compounds to treat inflammatory and immune disorders. Claim 1: A compound characterized by formulas (1), (2), (3), (4), (5), (6) or (7), or a pharmaceutically acceptable salt, a metabolite pharmaceutically active, a pharmaceutically acceptable prodrug or a pharmaceutically acceptable solvate thereof, wherein, Y is hydrogen, halo, cyano, C₁₋₃alkyl, C₁₋₃hydroxyalkyl, C₁₋₅alkenyl, C₁₋ ₃haloalkyl, C₁₋₃hydroxyhaloalkyl, C₃₋₆cycloalkyl, C₁₋₃alkoxy or C₁₋₃haloalkoxy; R¹ is hydrogen, C₁₋₆alkyl, C₁₋₆hydroxyalkyl or C₁₋₆haloalkyl; X is a compound selected from the group of formulas (8); R² is C₁₋₆alkyl, C₃₋₈cycloalkyl, C₃₋₈heterocycloalkyl, aryl or heteroaryl, optionally substituted with 1, 2, 3, 4 or 5 substituents independently selected, for each case, from the group consisting of halo, cyano, C₁₋₄alkyl , C₁₋₄haloalkyl, C₁₋₄cianoalkyl, hydroxyl, -OR, C₁₋₄hydroxyalkyl, C₁₋₄hydroxyalkoxy, C₁₋₄hydroxyalkoxyC₁₋₄alkyl, C₁₋₄alkoxy, C₁₋₄alkoxyC₁₋₄alkyl, C₁₋₄alkoxyC₁₋₄alkoxy, C₁₋₄alkoxyC₁₋₄alkoxyC₁₋ ₄alkyl, C₁₋₄haloalkoxy, -NR₂, (R₂N) C₁₋₄alkyl-, C₁₋₄alkylthio, C₁₋₄haloalkylthio, -C (= O) R, -C (= O) OR, -OC (= O) R, - C (= O) NR₂, -N (R) C (= O) R, -CH₂C (= O) R, -CH₂C (= O) OR, -CH₂OC (= O) R, -CH₂C (= O) NR₂ , -CH₂N (R) C (= O) R, -S (= O) ₂R, -S (= O) ₂NR₂, -N (R) S (= O) ₂R, -A and -CH₂A; R is independently selected, for each case, from the group consisting of hydrogen, C₁₋₄alkyl, C₁₋₄haloalkyl, C₁₋₄cianoalkyl, C₁₋₄hydroxyalkyl, C₃₋₈cycloalkyl or C₃₋₈heterocycloalkyl; or where a nitrogen is substituted with two R groups, which can be taken together with the nitrogen atom to which they are attached to form a saturated 4, 5, 6 or 7-membered C-heterocycloalkyl which, when formed, can be optionally substitute with 1, 2 or 3 substituents independently selected from the group consisting of C₁₋₄alkyl, halo, hydroxyl, C₁₋₄hydroxyalkyl, C₁₋₄cianoalkyl, C₁₋₄haloalkyl y = O; A is independently selected, for each case, from the group consisting of C₃₋₈cycloalkyl, C₃₋₈heterocycloalkyl, aryl and heteroaryl, optionally substituted with 1, 2, 3, 4 or 5 substituents independently selected, for each case, from the group consisting in halo, cyano, C₁₋₄alkyl, C₁₋₄haloalkyl, C₁₋₄cianoalkyl, hydroxyl, C₁₋₄hydroxyalkyl, C₁₋₄alkoxy, C₁₋₄alkoxyC₁₋₄alkyl, C₁₋₄haloalkoxy, -NR₂, (R₂N) C₁₋₄alquil-, C₁₋ Qualkylthio, C₁₋₄haloalkylthio, -C (= O) R, -C (= O) OR, -OC (= O) R, -C (= O) NR₂, -N (R) C (= O) R, -CH₂C (= O) R, -CH₂C (= O) OR, -CH₂OC (= O) R, -CH₂C (= O) NR₂, -CH₂N (R) C (= O) R, -S (= O) ₂R, -S (= O) ₂NR₂ and -N (R) S (= O) ₂R; W is a moiety selected from the group of formulas (9), optionally substituted with 1, 2, 3, 4 or 5 substituents independently selected, for each case, from the group consisting of halo, C₁₋₆alkyl, C₁₋₆hydroxyalkyl and C₁₋ Lohaloalkyl; R³ is C₁₋₆alkyl, C₃₋₈cycloalkyl, C₃₋₈heterocycloalkyl, aryl, heteroaryl, -C (= O) R⁴, -C (= O) OR⁴, -C (= O) N (R⁵) ₂ or -S (= O) ₂R⁴, optionally substituted with 1, 2, 3, 4 or 5 substituents independently selected, for each case, from the group consisting of halo, cyano, C₁₋₄alkyl, C₁₋₄haloalkyl, C₁₋₄cianoalkyl, hydroxyl, C₁₋₄hydroxyalkyl , C₁₋₄alkoxy, C₁₋₄alkoxyC₁₋₄alkyl, C₁₋₄haloalkoxy, -NR₂, (R₂N) C₁₋₄alkyl-, C₁₋₄alkylthio, C₁₋₄haloalkylthio, -C (= O) R, -C (= O) OR, -OC (= O) R, -C (= O) NR₂, -N (R) C (= O) R, -CH₂C (= O) R, -CH₂C (= O) OR, -CH₂OC (= O) R, -CH₂C (= O) NR₂, -CH₂N (R) C (= O) R, -S (= O) ₂R, -S (= O) ₂NR₂, -N (R) S (= O) ₂R, -A and -CH₂A; R⁴ is hydrogen, C₁₋₆alkyl, C₃₋₈cycloalkyl, C₃₋₈heterocycloalkyl, C₃₋₈cycloalkylC₁₋₆alkyl, C₃₋₈heterocycloalkylC₁₋₆alkyl, aryl or heteroaryl, optionally substituted with 1, 2, 3, 4 or 5 independently selected substituents, for each case, of the group consisting of halo, cyano, C₁₋₄alkyl, C₁₋₄haloalkyl, C₁₋₄cianoalkyl, hydroxyl, C₁₋₄hydroxyalkyl, C₁₋₄alkoxy, C₁₋₆alkoxyC₁₋₆alkyl, C₁₋₆haloalkoxy, -NR₂, (R₂N) C₁ Qualkyl, C₁₋₆alkylthio, C₁₋₆haloalkylthio, -C (= O) R, -C (= O) OR, -OC (= O) R, -C (= O) NR₂, -N (R) C ( = O) R, -CH₂C (= O) R, -CH₂C (= O) OR, -CH₂OC (= O) R, -CH₂C (= O) NR₂, -CH₂N (R) C (= O) R, - S (= O) ₂R, -S (= O) ₂NR₂, -N (R) S (= O) ₂R, -AY -CH₂A; and R⁵ is independently selected, for each case, from the group consisting of hydrogen, C₁₋₆alkyl, C₃₋₈cycloalkyl, C₃₋₈heterocycloalkyl, C₃₋₈cycloalkylC₁₋₆alkyl, C₃₋₈heterocycloalkylC₁₋₆alkyl, aryl and heteroaryl, optionally substituted with 1, 2, 3, 4 or 5 substituents, independently selected, for each case, from the group consisting of halo, cyano, C₁₋₄alkyl, C₁₋₄haloalkyl, C₁₋₄cianoalkyl, hydroxyl, C₁₋₄hydroxyalkyl, C₁₋₄alkoxy, C₁₋₄alkoxyC₁ Qualkyl, C₁₋₄haloalkoxy, -NR₂, (R₂N) C₁₋₄alkyl-, C₁₋₄alkylthio, C₁₋₄haloalkylthio, -C (= O) R, -C (= O) OR, -OC (= O) R, -C (= O) NR₂, -N (R) C (= O) R, -CH₂C (= O) R, -CH₂C (= O) OR, -CH₂OC (= O) R, -CH₂C (= O) NR₂, -CH₂N (R) C (= O) R, -S (= O) ₂R, -S (= O) ₂NR₂, -N (R) S (= O) ₂R, -A and -CH₂A; or wherein a nitrogen is substituted with two R⁵ groups that can be taken together with the nitrogen atom to which they are attached to form a saturated 4, 5, 6 or 7-membered heterocycloalkyl which, when formed, can optionally be substituted with 1, 2 or 3 substituents independently selected from the group consisting of C₁₋₄alkyl, halo, hydroxyl, C₁₋₄hydroxyalkyl, C₁₋₄haloalkyl y = O.
priorityDate 2013-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030

Total number of triples: 72.